MAPK3, as a critical component involved in the MAPK/ERK cascade pathway (Yang et al., 2019), and inhibition of MAPK3 can significantly inhibit cancer-stroma interactions and tumor metastasis (Yan et al., 2019). This evidence concerns the gene MAPK3 and neoplasm.